New user?
Forgot your password?
Document Actions
ARESA asbl, clinical research cluster
The Walloon Cluster of Clinical Research, ARESA, is a network of companies, academic and private research centers active in Clinical and Pharmaceutical Research. Wallonia has obvious advantages in clinical research: skills and infrastructures which qualities are acknowledged on the international level. The strategy of the cluster is to develop and optimize synergies and complementarities between industrial and scientific actors in clinical research by combining their expertise and fostering partnerships and commercial exchanges. Working in a network allows meeting speed criteria (reactions in accordance with the sector demands), quality criteria and marketing criteria (visibility and attractiveness). Launched in 2003, the cluster is now gathering more than a hundred and ten entities involved in clinical, medical and pharmaceutical research. These entities cover the various steps of clinical research: from preclinical to Phase IV: investigators, CRO, Biostatisticians, laboratories, regulatory, … With a Board of Directors composed of multi-disciplinary high caliber Professionals, University Professors and Doctors recognised as references in the Clinical Research Sector, the cluster of clinical research is the centralized organization where you will find any partner you need to fulfil your study in biotech, pharma, medical devices or nutrition, using Belgium as your bridge to EUROPE.
General Information
Country: Belgium
Region: RÉGION WALLONNE
Active since : 2003
Cluster Information
State of life: Established
Main activities: Clinical Research
Cluster Composition:
| Number of companies within the cluster: | 92 |
|---|---|
| Number of universities, technical colleges, schools or other education organisations within the cluster: | 9 |
| Number of non-industrial service providers (financial institutions, development agencies, utilities provider,..) within the cluster: | 8 |
| Number of others (individuals, consultants,...) within the cluster: | 5 |
| Number of companies with less than 50 employees within the cluster: | 84 |
| Number of companies with 50 and less than 250 employees within the cluster: | 14 |
| Number of companies with 250 and less than 500 employees within the cluster: | 4 |
| Number of companies with 500 and less than 1000 employees within the cluster: | 1 |
| Number of companies with more than 1000 employees within the cluster: | 6 |
Cooperation Objectives
Cooperation objectives:
|
General dissemination and information exchange
|
high
|
|
Networking, sharing/exchange of knowledge and expertise
|
high
|
|
Technology benchmarking / pre-assesment
|
medium
|
|
Technology transfer and exploitation of R&D results
|
medium
|
|
Search for partners for collaborative R&D
|
high
|
|
Access to markets / new customers
|
high
|
|
Access to suppliers
|
medium
|
|
Looking for technology, innovation advise and know-how
|
medium
|
|
Training, education, staff exchange
|
low
|
|
Establishment of subsidiaries and branch offices
|
low
|
Specific Cluster Characteristics
Ambition of the cluster:
| Region | Priority |
|---|---|
|
Regional
|
high
|
|
National
|
medium
|
|
European
|
medium
|
|
Worldwide
|
low
|
:
| Industry | Priority |
|---|---|
|
SME dominated
|
Yes
|
:
|
Applied research
|
Yes
|
Cooperation experience of the cluster management:
|
Regional
|
high
|
|
National
|
high
|
|
European
|
medium
|
|
International
|
low
|
Expertise and experience of the cluster in the following industrial activities:
| Experience | Priority |
|---|---|
|
Biotechnology
|
high
|
|
Medical technology
|
high
|
|
Agrifood technology
|
high
|
|
Environmental technology
|
medium
|
|
New materials and material sciences
|
high
|